scispace - formally typeset
X

Xiao-Hua Yu

Researcher at Hainan Medical University

Publications -  13
Citations -  929

Xiao-Hua Yu is an academic researcher from Hainan Medical University. The author has contributed to research in topics: ABCA1 & Reverse cholesterol transport. The author has an hindex of 4, co-authored 13 publications receiving 551 citations.

Papers
More filters
Journal ArticleDOI

Coronavirus disease 2019 (COVID-19): current status and future perspectives.

TL;DR: Intensive research on the newly emerged SARS-CoV-2 is urgently needed to elucidate the pathogenic mechanisms and epidemiological characteristics and to identify potential drug targets, which will contribute to the development of effective prevention and treatment strategies.
Journal ArticleDOI

Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis.

TL;DR: In this article, the authors describe decades of research aimed at identifying key molecules and cellular players involved in each main aspect of hepatic cholesterol metabolism and summarize the recent advances regarding the biological processes of liver cholesterol transport and its role in NAFLD and atherosclerosis.
Journal ArticleDOI

Resistin: Potential biomarker and therapeutic target in atherosclerosis.

TL;DR: Recent evidence about the pro- atherosclerotic effects of resistin is gathered and it is highlighted as a candidate therapeutic or diagnostic target for cardiovascular disease.
Journal ArticleDOI

CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p/LXRα pathway.

TL;DR: In this paper, the authors examined the influence of CTRP12 on atherosclerosis and explored the underlying mechanisms, showing that lentivirus-mediated CTRP-12 overexpression inhibited lipid accumulation and inflammatory response in lipid-laden macrophages.